Determined the high dose of OCU410ST to be the maximum tolerated doseNo serious adverse events have been reportedApproved ...

Chronic active antibody-mediated rejection (caAMR) is a common cause of allograft loss after transplantation, with no approved therapies. Clazakizumab, a monoclonal antibody that targets the ...

In the fourth quarter of 2024, we expect to announce updated data from the VTP-300 program in ongoing clinical trials in chronic hepatitis B at AASLD – The Liver Meeting® 2024 scheduled from November ...

Third quarter 2024 net revenue from global sales of IMCIVREE® (setmelanotide) of $33.3 million ---- Adult patients with acquired hypothalamic ...

Learn more about data risk in solar energy development in PV Tech's webinar with PVCase, next Wednesday 13th November at 4 pm ...

Instead, she carefully monitors each person’s reaction to the medication, tailoring the approach based on their body’s unique ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

Prescriptions of this GLP-1 class of diabetes and weight-loss medications ... monitor trade-offs between pharmacologic and ...

These days, it seems like nearly everyone I talk to is either on Ozempic or knows someone who is. Ozempic is actually one ...

While Ozempic’s weight loss benefits are widely touted, the conversation is increasingly shifting toward its side effects.

United's former player and coach reflects on managerial chaos, Ferguson's legacy, Ronaldo - and scouting a teenage Jude ...

Drs Pavan Brahmbhatt and Amit Agarwal discuss best practices for managing amyloid-related imaging abnormalities in patients ...